Loading…
Loading…
BU (Defiance Daily Target 2X Long B ETF) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
Dallas, Texas--(Newsfile Corp. - August 13, 2026) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). Burcon's 1Q27 results reinforce the transition from technology validation to commercial execution.
Dallas, Texas--(Newsfile Corp. - June 26, 2026) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). Burcon has moved from commissioning and into early utilization, with growing customer volume setting up better fixed-cost absorption at Galesburg.
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will hold an investor conference call and webcast on Wednesday, June 24, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal year ended March 31, 2026.
Advancing Burcon's commercialization journey through growing commercial traction and manufacturing scale Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based proteins, today announced continued commercial and operational momentum, highlighted by strong growth in sales compared to the previous quarter and the establishment of a new production record with its manufacturing partner, marking another milestone in Burcon's transition from technology development to commercial-scale ingredient sales. "Approximately 50% growth in sales compared to the previous quarter, combined with record production performance, reflects the continued transition of Burcon from technology development to commercial-scale ingredient sales," said Kip Underwood, Chief Executive Officer of Burcon.
NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Tidal Financial Group and Defiance ETFs today announced their decision to close and liquidate two exchange-traded funds: the Defiance Daily Target 2X Long B ETF (Nasdaq: BU), and the Defiance Daily Target 2X Long CVNA ETF (Nasdaq: CVNX). The final day of trading for BU and CVNX (the “funds”) on the Nasdaq will be Monday, June 8, 2026.
Burcon NutraScience Co. (TSE: BU - Get Free Report) (NYSE: BUR)'s stock price passed above its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of C$2.08 and traded as high as C$2.30. Burcon NutraScience shares last traded at C$2.30, with a volume of 3,226 shares trading hands. Burcon NutraScience Stock
Burcon NutraScience Co. (TSE: BU - Get Free Report) (NYSE: BUR) shares passed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of C$2.06 and traded as high as C$2.08. Burcon NutraScience shares last traded at C$1.86, with a volume of 3,416 shares. Burcon NutraScience
Burcon NutraScience Corporation (BU:CA) Shareholder/Analyst Call Prepared Remarks Transcript
SEC filings for BU aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.